Abstract

There is a shift in antimalarial drug discovery from phenotypic screening toward target-based approaches, as more potential drug targets are being validated in Plasmodium species. Given the high attrition rate and high cost of drug discovery, it is important to select the targets most likely to deliver progressible drug candidates. In this paper, we describe the criteria that we consider important for selecting targets for antimalarial drug discovery. We describe the analysis of a number of drug targets in the Malaria Drug Accelerator (MalDA) pipeline, which has allowed us to prioritize targets that are ready to enter the drug discovery process. This selection process has also highlighted where additional data are required to inform target progression or deprioritization of other targets. Finally, we comment on how additional drug targets may be identified.

Highlights

  • There is a shift in antimalarial drug discovery from phenotypic screening toward target-based approaches, as more potential drug targets are being validated in Plasmodium species

  • Malaria is caused by Anopheles mosquito-transmitted protozoan Plasmodium parasites

  • P. falciparum is associated with the most deaths, infections due to P. vivax and P. knowlesi can cause severe disease

Read more

Summary

Prioritization of Molecular Targets for Antimalarial Drug Discovery

Barbara Forte,$ Sabine Ottilie,$ Andrew Plater,$ Brice Campo, Koen J.

Treating active disease
Irresistible no resistance found in selections
Structural information
■ ACKNOWLEDGMENTS
Findings
■ REFERENCES

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.